NanoVision Diagnostics

About:

NanoVision Diagnostics is commercializing a novel electro-optical cancer diagnostic system.

Website: http://nanovisiondiagnostics.com

Top Investors: Innovation Works, North Coast Ventures

Description:

NanoVision Diagnostics is commercializing a novel electro-optical cancer diagnostic system. The company develops an optical biomarker intended to offer cancer detection services that conduct an optical analysis of a standard biopsy slide to detect molecular changes in nuclear structure not detectable by pathology that enables medical practitioners to detect and treat cancer in the early stages.

Total Funding Amount:

$1.5M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Kittanning, Pennsylvania, United States

Founded Date:

2013-01-01

Contact Email:

mike.lang(AT)nanovisiondiagnostics.com

Founders:

Bernie Hete, Michael Lang

Number of Employees:

11-50

Last Funding Date:

2014-01-10

IPO Status:

Private

Industries:

© 2025 bioDAO.ai